Last update 02 May 2024
Sumitomo Pharma Co., Ltd.

Sumitomo Pharma Co., Ltd.

Public Company|
1984|
Osaka-fu, Japan
|
5,000-10,000
| TYO: 4506|

Overview

Basic Info

Introduction
Sumitomo Pharma Group, prioritizing Psychiatry & Neurology and Oncology as core disease areas, is committed to enhancing global healthcare and enriching the lives of individuals. This commitment is pursued through a multidimensional strategy that encompasses pharmaceutical products, regenerative medicine/cell therapy, and innovative non-pharmaceutical solutions. Moreover, the Group effectively utilizes its assets to provide valuable contributions to patients across various other medical fields.

Tags

Nervous System Diseases
Other Diseases
Endocrinology and Metabolic Disease
Small molecule drug
Induced pluripotent stem cells (iPSC)
Shared antigen vaccine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug102
Induced pluripotent stem cells (iPSC)4
Unknown3
Therapeutic vaccine2
Shared antigen vaccine2

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Jun 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
13
17
Preclinical
Phase 1 Clinical
13
14
Phase 2 Clinical
Phase 3 Clinical
4
1
NDA/BLA
Approved
64
175
Other
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free